Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurogastroenterology and Motility|August 31, 2007
Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflexB Yuece, A Sibaev, U C Broedl, et al.Diabetes, Obesity & Metabolism|March 17, 2015
Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitusE Araki, Y Tanizawa, Y Tanaka, et al.Diabetes, Obesity & Metabolism|June 18, 2015
Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)T R Pieber, S Famulla, J Eilbracht, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 3, 2015
Empagliflozin as add-on to metformin in people with Type 2 diabetesL Merker, H-U Häring, A V Christiansen, et al.Pageof 2